Cortland Med Center
Houston, TX
PROPERTY OVERVIEW
Cortland Med Center is a 344-unit, 2003-built apartment complex in the Med Center submarket of Houston.
- The property received the 2023 Kingsley Excellence Award for resident satisfaction. We will take over a turnkey community with stable returns and minimal concern about major capital projects in the future.
- Cortland Med Center benefits strongly from Houston’s ongoing population growth. The property offers excellent connectivity to Central Houston’s employment with 326,000 jobs within a five-mile radius and 983,000 jobs within a 10-mile radius.
- Less than 10 minutes away, the Texas Medical Center (TMC) is the largest life sciences destination in the world with 106,000 employees. Given that most of the land is occupied by TMC institutions, there is limited available land for development, mitigating the threat of new supply.
- Current / Stabilized / Breakeven Occupancy: 93.3% / 95.0% / 69.7%
In-Place Rent / Pro Forma: $1,503 / $1,473
INVESTOR RETURNS
- Our sponsor team will partner with the Houston Housing Authority (HHA) on their 11th deal to receive an 85% tax exemption will increase our NOI by 29% on Day 1
- Limited Partners are owed an 8% preferred return
- Shortfalls in this preferred payment will accrue and compound at the preferred return rate.
- Upon a capital event, investors are first entitled to their preferred return and 100% return of their original capital.
- Thereafter, excess proceeds from 8–15% IRR are split 70% LP / 30% GP, and above 15% IRR, 50% LP / 50% GP.
- Class B shares are available via a minimum investment of $500k and provide a 9% preferred return with a 30% promote (no secondary hurdle).
- Investors receive 100% of ongoing cashflow, as well as a compounding 8% IRR-based preferred return above the full return of initial investment, before any performance incentive is paid to the sponsor.
- Preferred return is cumulative and compounding, rather than the simple cashflow split often seen in other investments.
Fill out the form below to soft commit:
Start Investing Alongside Us Today
The testimonials, statements, and opinions presented are applicable to the individuals listed. Results will vary and may not be representative of the experience of others. The testimonials are voluntarily provided and are not paid, nor were they provided with free products, services, or any benefits in exchange for said statements. The testimonials are representative of client experience, but the exact results and experience will be unique and individual to each client. All offers and sales of any securities will be made only to Accredited Investors, which for natural persons, are investors who meet certain minimum annual income or net worth thresholds or hold certain SEC approved certifications. Any securities that are offered, are offered in reliance on certain exemptions from the registration requirements of the Securities Act of 1933 (primarily Rule 506C of Regulation D and/or Section 4(a)(2) of the Act) and are not required to comply with specific disclosure requirements that apply to registrations under the Act. The SEC has not passed upon the merits of, or given its approval to any securities offered by Timberview Capital LLC, the terms of the offering, or the accuracy of completeness of any offering materials. Any securities that are offered by Timberview Capital LLC are subject to legal restrictions on transfer and resale and investors should not assume they will be able to resell any securities offered by Timberview Capital LLC. Investing in securities involves risk, and investors should be able to bear the loss of their investment. Any securities offered by Timberview Capital LLC are not subject to the protections of the Investment Company Act. Any performance data shared by Timberview Capital LLC represents past performance and past performance does not guarantee future results. Neither Timberview Capital LLC nor any of its funds are required by law to follow any standard methodology when calculating and representing performance data and the performance of any such funds may not be directly comparable to the performance of other private or registered funds.